Tang Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Tang Capital Management’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-977,626	Closed	-$2.6M	–	142
2024 Q1	$2.6M	Sell	977,626 -1,624,021	-62%	-$4.02M	0.27%	72
2023 Q4	$6.17M	Buy	+2,601,647	New	+$4.61M	0.57%	42

Tang Capital Management's KNTE Position: Q2 2024 in Review

Tang Capital Management sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 977,626 shares — an estimated $2.6M sold.

Tang Capital Management first reported a position in KNTE in Q4 2023 and held it in 2 quarters. The position peaked at $6.17M in Q4 2023. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Tang Capital Management reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Tang Capital Management sold 977,626 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $2.6M.
Tang Capital Management first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Tang Capital Management's Kinnate Biopharma Inc. Common Stock position peaked at $6.17M in Q4 2023.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Tang Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.